Femasys (FEMY) Convertible Debt (2023 - 2025)

Femasys (FEMY) posted Convertible Debt of $3.2 million for Q4 2025, down 37.28% on a QoQ basis from $5.1 million in Q3 2024.

Femasys (FEMY) Convertible Debt (2023 - 2025) Analysis & Trends

Femasys' Convertible Debt history runs 3 years deep, the most recent figure standing at $3.2 million for Q4 2025.

Quarterly Convertible Debt changed N/A year-over-year to $3.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (changed N/A YoY) and the FY2025 annual result came in at $3.2 million, changed N/A from the prior year.
Convertible Debt was $3.2 million for Q4 2025 at Femasys, down from $5.1 million in the prior quarter.
Across five years, Convertible Debt topped out at $5.1 million in Q3 2024 and bottomed at $3.2 million in Q4 2025.
A 3-year average of $4.3 million and a median of $4.5 million in 2024 frame the typical range for Convertible Debt.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Femasys	17.46 Mn	12.07 Mn	-

Download Data